Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Terrier

Showing results (81-90 of 444) with videos related to

Pageof 45
Sort By:
Internal and Emergency Medicine|August 8, 2019
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study GroupChiara Marvisi, Renato Alberto Sinico, Carlo Salvarani, et al.
Critical Care (London, England)|December 6, 2018
Effect of plasma exchange in acute respiratory failure due to Anti-neutrophil cytoplasmic antibody-associated vasculitisGuillaume Geri, Benjamin Terrier, Farhad Heshmati, et al.
Journal of Autoimmunity|April 8, 2014
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patientsAna Luisa Calich, Xavier Puéchal, Grégory Pugnet, et al.
Journal of Clinical Medicine|June 2, 2021
Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitidesCamille Roubille, Soledad Henriquez, Cédric Mercuzot, et al.
RMD Open|October 30, 2023
Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trialXavier Romand, Marie Hélène Paclet, Minh Vu Chuong, et al.
Clinical and Experimental Rheumatology|June 5, 2019
Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitisAnnalisa Montante, Alicia Le Bras, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|June 22, 2021
Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)Silvia Sartorelli, Guillaume Chassagnon, Pascal Cohen, et al.
The American Journal of Medicine|June 15, 2015
Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertensionJérémie Dion, Benjamin Terrier, Xavier Jaïs, et al.
Arthritis Care & Research|May 23, 2022
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage AccrualPaolo Delvino, Federica Sardanelli, Sara Monti, et al.
Autoimmunity Reviews|May 12, 2015
Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patientsBertrand Dunogué, Benjamin Terrier, Pascal Cohen, et al.
Pageof 45

Showing results (81-90 of 444) with videos related to

Sort By:
Pageof 45
Internal and Emergency Medicine|August 8, 2019
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study GroupChiara Marvisi, Renato Alberto Sinico, Carlo Salvarani, et al.
Critical Care (London, England)|December 6, 2018
Effect of plasma exchange in acute respiratory failure due to Anti-neutrophil cytoplasmic antibody-associated vasculitisGuillaume Geri, Benjamin Terrier, Farhad Heshmati, et al.
Journal of Autoimmunity|April 8, 2014
Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patientsAna Luisa Calich, Xavier Puéchal, Grégory Pugnet, et al.
Journal of Clinical Medicine|June 2, 2021
Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitidesCamille Roubille, Soledad Henriquez, Cédric Mercuzot, et al.
RMD Open|October 30, 2023
Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trialXavier Romand, Marie Hélène Paclet, Minh Vu Chuong, et al.
Clinical and Experimental Rheumatology|June 5, 2019
Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitisAnnalisa Montante, Alicia Le Bras, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|June 22, 2021
Revisiting characteristics, treatment and outcome of cardiomyopathy in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss)Silvia Sartorelli, Guillaume Chassagnon, Pascal Cohen, et al.
The American Journal of Medicine|June 15, 2015
Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertensionJérémie Dion, Benjamin Terrier, Xavier Jaïs, et al.
Arthritis Care & Research|May 23, 2022
Remission and Low Disease Activity in Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage AccrualPaolo Delvino, Federica Sardanelli, Sara Monti, et al.
Autoimmunity Reviews|May 12, 2015
Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: A long-term retrospective study on 42 patientsBertrand Dunogué, Benjamin Terrier, Pascal Cohen, et al.
Pageof 45